Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 9.8M | 8.3M | 15.5M | 2.5M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -110.5M | -91.5M | -72.4M | -162.4M |
| EBITDA | — | — | — | — |
| Net Income | -109.0M | -89.3M | -111.6M | -166.0M |
| Per Share Data | ||||
| EPS (diluted) | $-0.34 | $-0.36 | $-0.96 | $-3.78 |
| Shares Outstanding (dil.) | 320M | 250M | 116M | 44M |
Taysha Gene Therapies Inc. Income Statement — FAQ
Taysha Gene Therapies Inc. (TSHA) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's income statement history?
The chart and table above show Taysha Gene Therapies Inc.'s income statement by year and by quarter, including the growth rate.